Literature DB >> 19169828

Nanobiology for the pharmacology of cellular ion channels.

Alexander V Kabanov1, Mikhail P Kirpichnikov, Alexey R Khokhlov.   

Abstract

Writing this editorial is especially pleasing. First, it provides us an opportunity to introduce new directives to the field of Neuroimmune Pharmacology and to explain why the field of nanomedicine is likely an important part of its future growth and development. Second, it is an opportunity to showcase research in this area currently operative in Russia that may not be readily accessible to the readership. Third, it is a platform to better explain why the Journal Editorial leadership was enthusiastic about the science and its relationship to the Society on NeuroImmune Pharmacology strategic goals. All are brought to bear in this issue of the Journal of Neuroimmune Pharmacology. The issue includes articles presented at a recent joint US-Russian workshop entitled, "Health in the 21st Century: Nanomedicine and Self-Organization of Biological Systems" held at M.V. Lomonosov Moscow State University (MSU), Moscow, Russia, December 10-11, 2007. The conjoint meeting was organized through the Departments of Biology, Chemistry, and Physics, MSU and by the Center for Drug Delivery and Nanomedicine and Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center (Omaha, NE). The speakers included established internationally regarded scientists from these institutions as well as graduate students and faculties at MSU. In addition to selected papers by workshop contributors, we have included several papers closely aligned to the theme of nanomedicine and nanopharmacology of the central nervous system in order to provide a biological anchor for this research. We understand that such works are new to many but hope that its organization and interdisciplinary approaches will appeal to this audience. All together, it is our hope that, by gathering basic and clinical scientists with the common interest of using nanotechnology in the delivery of therapeutic agents with a focus on nanopharmacology and complex supramolecular biological assembly, the papers included will provide a platform for thought, discussion, and future translational research.

Mesh:

Substances:

Year:  2009        PMID: 19169828     DOI: 10.1007/s11481-008-9144-0

Source DB:  PubMed          Journal:  J Neuroimmune Pharmacol        ISSN: 1557-1890            Impact factor:   4.147


  8 in total

1.  Early stages for Parkinson's development: alpha-synuclein misfolding and aggregation.

Authors:  Junping Yu; Yuri L Lyubchenko
Journal:  J Neuroimmune Pharmacol       Date:  2008-07-17       Impact factor: 4.147

2.  Effect of pluronic p85 on amino acid transport in bovine brain microvessel endothelial cells.

Authors:  Xiaobin Zhang; Daria Y Alakhova; Elena V Batrakova; Shu Li; Zhihui Yang; Yili Li; Alexander V Kabanov
Journal:  J Neuroimmune Pharmacol       Date:  2008-08-02       Impact factor: 4.147

Review 3.  The domain and conformational organization in potassium voltage-gated ion channels.

Authors:  Anastasia V Pischalnikova; Olga S Sokolova
Journal:  J Neuroimmune Pharmacol       Date:  2008-10-03       Impact factor: 4.147

4.  A novel model system for design of biomaterials based on recombinant analogs of spider silk proteins.

Authors:  Vladimir G Bogush; Olga S Sokolova; Lyubov I Davydova; Dmitri V Klinov; Konstantin V Sidoruk; Natalya G Esipova; Tatyana V Neretina; Igor A Orchanskyi; Vsevolod Yu Makeev; Vladimir G Tumanyan; Konstantin V Shaitan; Vladimir G Debabov; Mikhail P Kirpichnikov
Journal:  J Neuroimmune Pharmacol       Date:  2008-10-07       Impact factor: 4.147

Review 5.  Voltage-gated potassium channels in human immunodeficiency virus type-1 (HIV-1)-associated neurocognitive disorders.

Authors:  James Keblesh; Dehui Hu; Huangui Xiong
Journal:  J Neuroimmune Pharmacol       Date:  2008-05-06       Impact factor: 4.147

6.  Monocyte chemotactic protein-1 regulates voltage-gated K+ channels and macrophage transmigration.

Authors:  Howard E Gendelman; Shengyuan Ding; Nan Gong; Jianuo Liu; Servio H Ramirez; Yuri Persidsky; R Lee Mosley; Tong Wang; David J Volsky; Huangui Xiong
Journal:  J Neuroimmune Pharmacol       Date:  2008-11-26       Impact factor: 4.147

7.  Targeted transport of 125I-labeled antibody to GFAP and AMVB1 in an experimental rat model of C6 glioma.

Authors:  Vladimir P Chekhonin; Vladimir P Baklaushev; Gaukhar M Yusubalieva; Olga I Gurina
Journal:  J Neuroimmune Pharmacol       Date:  2008-09-04       Impact factor: 4.147

8.  Recombinant Kv channels at the membrane of Escherichia coli bind specifically agitoxin2.

Authors:  Oksana V Nekrasova; Anastasia A Ignatova; Anna I Nazarova; Alexey V Feofanov; Yuliya V Korolkova; Elena F Boldyreva; Anna I Tagvei; Eugene V Grishin; Alexander S Arseniev; Mikhail P Kirpichnikov
Journal:  J Neuroimmune Pharmacol       Date:  2008-07-23       Impact factor: 4.147

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.